导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 42.37% | 474/3406 |
| 近一周 | -4.07% | 3865/4642 |
| 近一月 | -1.17% | 676/4620 |
| 近一季 | -0.38% | 1955/4441 |
| 近半年 | 46.84% | 386/3981 |
| 近一年 | 38.66% | 524/3342 |
| 近两年 | 64.19% | 347/2453 |
| 近三年 | 30.55% | 637/1947 |
| 成立以来 | 25.90% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
-1.81% 2783/3635 |
3.20% 1116/4076 |
47.60% 445/4523 |
- - |
| 2024 | 12.85% 1205/3464 |
-3.65% 1535/2808 |
-6.26% 1896/3014 |
27.35% 231/3130 |
-1.89% 1877/3464 |
| 2023 | -17.84% 1761/2655 |
2.19% 1417/2280 |
-6.80% 1712/2385 |
-9.02% 1768/2515 |
-5.18% 1281/2655 |
| 2022 | -27.89% 1513/2208 |
-19.06% 1424/1919 |
5.76% 831/2016 |
-17.65% 1629/2113 |
2.29% 987/2208 |
| 2021 | 11.61% 400/1822 |
-6.32% 994/1255 |
24.71% 108/1330 |
-6.54% 952/1466 |
2.22% 657/1822 |
| 2020 | 61.94% 118/1246 |
3.86% 105/1028 |
28.79% 93/1067 |
5.52% 912/1164 |
14.72% 254/1184 |
| 2019 | 40.88% 243/1092 |
32.80% 160/739 |
-9.53% 663/788 |
6.91% 110/850 |
9.68% 210/918 |
| 2018 | -25.64% 360/834 |
- - |
-14.16% 483/631 |
-11.11% 567/660 |
-10.20% 181/682 |
| 2017 | -12.76% 554/714 |
- - |
- - |
- - |
- - |
| 2016 | -26.38% 491/605 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 易方达标普生物科技美元汇A | 0.2432 | 29.46% |
| 易方达标普生物科技美元汇C | 0.2399 | 28.01% |
| 汇安行业龙头混合A | 2.4323 | 22.37% |
| 华商致远回报混合A | 1.6762 | 21.58% |
| 广发生物科技指数美元(QDII)C | 0.2047 | 18.46% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)美元现汇 | 1.3424 | 17.84% |
| 华夏上证科创板半导体材料设备主题ETF联接C | 1.2373 | 17.83% |
| 宝盈国家安全沪港深股票C | 2.1469 | 17.42% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)人民币A | 1.3726 | 17.14% |
| 广发上海金ETF | 9.7032 | 16.81% |
| 天弘创业板ETF联接C VS. () |